Market Research Report Title Publication Date Pages Price
Ataxia - Market Insights, Epidemiology and Market Forecast 120 USD 6,250.00
Sedation - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Thrombotic Thrombocytopenic Purpura - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Traveler's Diarrhea - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Secondary Progressive Multiple Sclerosis (SPMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Thrombocytopenia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Thyroid Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Severe Psoriasis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 120 USD 2,250.00
Seizures - Global API Manufacturers, Marketed and Phase III Drugs Landscape 150 USD 2,250.00
Relapsing Multiple Sclerosis (RMS) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Rhinosinusitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Rhino-Conjunctivitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Secondary Hyperparathyroidism - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Renal Anemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Restless Legs Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Rosacea - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Relapsed Chronic Lymphocytic Leukemia (CLL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Retinal Vein Occlusion - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Seasonal Allergic Rhinitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 120 USD 2,250.00
Raynauds Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Pulmonary Embolism - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Malignant Glioma - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Primary Immune Deficiency (PID) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Pyelonephritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Psoriatic Arthritis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 120 USD 2,250.00
Pulmonary Arterial Hypertension - Global API Manufacturers, Marketed and Phase III Drugs Landscape 120 USD 2,250.00
Premature Labor (Tocolysis) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Premature Ejaculation - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Postherpetic Neuralgia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Post-Traumatic Stress Disorder (PTSD) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Primary Biliary Cirrhosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Porphyria - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Pouchitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Post Menopausal Osteoporosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 120 USD 2,250.00
Polycystic Kidney Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Systemic Mastocytosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Polycythemia - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Spinal Muscular Atrophy (SMA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Pompe Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Systemic Lupus Erythematosus - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Phenylketonuria (PKU) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Systemic Juvenile Idiopathic Arthritis (SJIA) - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Spasticity - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Non-Small Cell Lung Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Tourette Syndrome - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Sarcoidosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Smallpox - Global API Manufacturers, Marketed and Phase III Drugs Landscape 40 USD 1,500.00
Sickle Cell Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Soft Tissue Sarcoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape 60 USD 2,000.00
Displaying 101 - 150 of 2417
Subscribe to Drug Pipeline